Skip to content

Diagnosis of postpartum haemorrhage at caesarean births

Diagnosis of postpartum haemorrhage at caesarean section: a multi-country diagnostic and prognostic accuracy study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202602844431769
Enrollment
1245
Registered
2026-02-06
Start date
2025-11-03
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childbirth and postpartum care

Interventions

Colorimetric measurement of blood loss and gravimetric and volumetric measurement of blood loss

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: • Women aged 18 or over • Women undergoing birth by caesarean section (elective or semi-emergency [category 2 or 3]) during the study period. Multiple pregnancies will be eligible. • Written informed consent from participants.

Exclusion criteria

Exclusion criteria: • Women undergoing a category 1 (immediate threat to life) caesarean section. • Women undergoing a caesarean section with a planned hysterectomy • Women participating in another PPH study. • Women diagnosed major bleeding disorder

Design outcomes

Primary

MeasureTime frame
Primary outcome will be a composite of any of the following: blood transfusion, Hb <6g/dL or a decrease of 4g/dL or greater from baseline, as well as PPH-related procedures (compression sutures, major vessel ligation or hysterectomy), maternal HDU/ICU admission, or maternal mortality.

Secondary

MeasureTime frame
Severe PPH during CS - PPH- defined as =1000 mL measured blood loss intraoperatively during CS (total calculated at the end of the procedure);Blood loss volume during CS in theatre - Volume of blood lost intraoperatively during CS (total calculated at the point of PPH diagnosis and at the end of the procedure) (mL);Primary PPH - blood loss greater than or equal to 500mL within the first 24 hours after delivery. ;Blood transfusion - Transfusion of whole blood or blood products given to the patient to replace that lost during Caesarean section when required;Haemoglobin <6g/dL or a decrease of 4g/dL or greater from baseline - pre-operative Hb taken in the 36 hours preceding surgery; post-operative Hb measurement taken 6-24 hours after surgery. ;PPH-related Hysterectomy - Hysterectomy (surgical removal of uterus) required to control bleeding during or after caesarean section until discharge;Any hysterectomy - Hysterectomy (surgical removal of uterus) required to control bleeding during or after caesarean section until discharge;PPH-related re-laparotomy - Return to theatre and re-laparotomy procedure to facilitate further treatment for PPH. ;Any laparotomy - Return to theatre and re-laparotomy procedure ;PPH-related maternal mortality - Death of a mother from PPH during and after caesarean section up until discharge;All-cause mortality - Death of a mother during and after caesarean section up until discharge;PPH-related admission to the HDU/ICU - Woman requiring admission to HDU/ICU following a caesarean section complicated by bleeding and related sequalae. ;Any admission to the HDU/ICU - Woman requiring admission to HDU/ICU following a caesarean section ;PPH-related major vessel ligation - Uterine and iliac artery ligation are surgical procedures used to control/stop bleeding during caesarean section from the uterus and pelvis in an attempt to preserve the uterus and save the mother’s life. ;Uterine tourniquet - A surgical technique used to temporarily control severe

Countries

India, Kenya, Nigeria, Pakistan, Rwanda

Contacts

Public ContactSindhu Natarajan

Programme Manager

c.sindhukn@bham.ac.uk+441214147878

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026